Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

B4 androgen ablation: attacking the prostate cancer stem cell.

Wicha MS.

J Clin Invest. 2013 Feb;123(2):563-5. doi: 10.1172/JCI67460.

2.

β4 Integrin signaling induces expansion of prostate tumor progenitors.

Yoshioka T, Otero J, Chen Y, Kim YM, Koutcher JA, Satagopan J, Reuter V, Carver B, de Stanchina E, Enomoto K, Greenberg NM, Scardino PT, Scher HI, Sawyers CL, Giancotti FG.

J Clin Invest. 2013 Feb;123(2):682-99. doi: 10.1172/JCI60720.

3.

New insights into prostate cancer stem cells.

Chen X, Rycaj K, Liu X, Tang DG.

Cell Cycle. 2013 Feb 15;12(4):579-86. doi: 10.4161/cc.23721. Review.

4.
5.

Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.

Seiler D, Zheng J, Liu G, Wang S, Yamashiro J, Reiter RE, Huang J, Zeng G.

Prostate. 2013 Sep;73(13):1378-90. doi: 10.1002/pros.22685.

PMID:
23728788
6.

SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells.

Rybak AP, Tang D.

Cell Signal. 2013 Dec;25(12):2734-42. doi: 10.1016/j.cellsig.2013.08.041.

PMID:
24036214
7.

Early human prostate adenocarcinomas harbor androgen-independent cancer cells.

Fiñones RR, Yeargin J, Lee M, Kaur AP, Cheng C, Sun P, Wu C, Nguyen C, Wang-Rodriguez J, Meyer AN, Baird SM, Donoghue DJ, Haas M.

PLoS One. 2013 Sep 25;8(9):e74438. doi: 10.1371/journal.pone.0074438.

8.

Gene signatures distinguish stage-specific prostate cancer stem cells isolated from transgenic adenocarcinoma of the mouse prostate lesions and predict the malignancy of human tumors.

Mazzoleni S, Jachetti E, Morosini S, Grioni M, Piras IS, Pala M, Bulfone A, Freschi M, Bellone M, Galli R.

Stem Cells Transl Med. 2013 Sep;2(9):678-89. doi: 10.5966/sctm.2013-0041.

9.

Prostate cancer and metastasis initiating stem cells.

Kelly K, Yin JJ.

Cell Res. 2008 May;18(5):528-37. doi: 10.1038/cr.2008.50. Review.

10.

Activation of c-MET induces a stem-like phenotype in human prostate cancer.

van Leenders GJ, Sookhlall R, Teubel WJ, de Ridder CM, Reneman S, Sacchetti A, Vissers KJ, van Weerden W, Jenster G.

PLoS One. 2011;6(11):e26753. doi: 10.1371/journal.pone.0026753.

11.

Identification, characterization, and biological relevance of prostate cancer stem cells from clinical specimens.

Kasper S.

Urol Oncol. 2009 May-Jun;27(3):301-3. doi: 10.1016/j.urolonc.2008.12.012. Review.

12.
13.
14.

Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy.

Sun Y, Wang BE, Leong KG, Yue P, Li L, Jhunjhunwala S, Chen D, Seo K, Modrusan Z, Gao WQ, Settleman J, Johnson L.

Cancer Res. 2012 Jan 15;72(2):527-36. doi: 10.1158/0008-5472.CAN-11-3004.

15.

NOTCH1 signaling promotes chemoresistance via regulating ABCC1 expression in prostate cancer stem cells.

Liu C, Li Z, Bi L, Li K, Zhou B, Xu C, Huang J, Xu K.

Mol Cell Biochem. 2014 Aug;393(1-2):265-70. doi: 10.1007/s11010-014-2069-4.

PMID:
24782036
16.

Prostate cancer stem-like cells proliferate slowly and resist etoposide-induced cytotoxicity via enhancing DNA damage response.

Yan J, Tang D.

Exp Cell Res. 2014 Oct 15;328(1):132-42. doi: 10.1016/j.yexcr.2014.08.016.

PMID:
25149681
17.

Stem cells in prostate cancer: resolving the castrate-resistant conundrum and implications for hormonal therapy.

Sharifi N, Kawasaki BT, Hurt EM, Farrar WL.

Cancer Biol Ther. 2006 Aug;5(8):901-6. Review.

PMID:
16855379
18.

[Prostate cancer stem cells: advances in current research].

Wu G, Wu DL.

Zhonghua Nan Ke Xue. 2015 Feb;21(2):170-4. Review. Chinese.

PMID:
25796694
19.

MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.

Hsieh IS, Chang KC, Tsai YT, Ke JY, Lu PJ, Lee KH, Yeh SD, Hong TM, Chen YL.

Carcinogenesis. 2013 Mar;34(3):530-8. doi: 10.1093/carcin/bgs371.

20.

Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line.

Watson PA, Ellwood-Yen K, King JC, Wongvipat J, Lebeau MM, Sawyers CL.

Cancer Res. 2005 Dec 15;65(24):11565-71.

Items per page

Supplemental Content

Support Center